Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Tachyon Ventures is a venture capital firm based in the United States, focusing on early-stage investments in medicine, biotech, and bioengineering. Founded to provide smart capital, they support entrepreneurs advancing scientific research and technology. The firm has a portfolio of 10 companies and collaborates with scientists from leading research institutions.
Tachyon Ventures specializes in pre-seed to Series A investments in biotech and healthcare. Their investment thesis emphasizes scientific risk-arbitrage, targeting companies with protected intellectual property and recognized research teams. Typical investments are made in transformative technologies that show promise in early development stages.
Notable companies in Tachyon Ventures' portfolio include Mammoth Biosciences, a CRISPR-based platform for healthcare tests; Enclear Therapies, which focuses on halting neurodegenerative diseases; and DTx Pharma, known for its siRNA delivery platform. Other investments include Scipher Medicine, Forkhead, and EpiBone.
Submit your pitch through their website's contact form for consideration.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.